David Holtzman on China Approves Seaweed Sugar as First New Alzheimer’s Drug in 17 Years
COMMENT The compound GV-971, Sodium oligomannate, was recently tested in a people who, based on clinical criteria, had mild to moderate dementia believed to be due to Alzheimer’s disease. Over a 36-week period, participants on GV-971 performed better than placebo ...